The Phase 3 EPIC trial is a randomized, sham-controlled, double-blind study evaluating NRTX-1001 cell therapy in adults with ...

Recent research takes aim at the a variant in gene SCN1B, which causes a severe form of developmental epileptic encephalopathy.

Administering the therapy to newborn mice increased their survival, reduced the severity of their seizures and restored brain neuron excitability. The team notes that different forms of SCN1B gene ...

Discover how MR-guided focused ultrasound offers a revolutionary non-invasive treatment for tremors and epilepsy reducing ...

The Phase 3 EPIC trial is a randomized, sham-controlled, double-blind study evaluating NRTX-1001 cell therapy in adults with drug-resistant mesial temporal lobe epilepsy SAN FRANCISCO, Feb.

New Delhi, February 15 (IANS) A team of researchers has developed a new gene therapy for children with Dravet syndrome -- a rare type of epilepsy in children. Dravet syndrome (DS) is a ...

New Delhi, Feb 15 (IANS): A team of researchers has developed a new gene therapy for children with Dravet syndrome -- a rare type of epilepsy in children. Dravet syndrome (DS) is a developmental and ...

Epilepsy is a neurological disorder that disrupts nerve cell activity in the brain yet a normal life can be led with therapy ...

Changes in the frequency of epilepsy, 50% and 75% responder rates, and seizure freedom rates from baseline to the maintenance period and adherence score were assessed. In addition, adverse events (AEs ...

No seizures have been reported in the PROPHYLAXIS-group for the whole length of the ... On the contrary, patients treated with prophylactic therapy with LEV do not exhibit increased glutamate ...